Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Non-compliance with PCOS medication worsens symptoms and highlights the need for better patient support and education.

Androgens significantly affect female hair loss, and hormonal treatments may help.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Finasteride improves hair loss in women with hyperandrogenism.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Exercise and finasteride together improve ovary health in PCOS rats.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

PCOS-related infertility is managed with lifestyle changes and medications.

A holistic approach, including lifestyle changes and surgery, is recommended for better long-term PCOS management.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Insulin resistance varies among PCOS types, and simple math tools can help identify it early.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.